Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Presence of minor and major mental health impairment in adolescence and death from suicide and unintentional injuries/accidents in men: a national longitudinal cohort study.

Fadum EA, Fønnebø V, Borud EK.

J Epidemiol Community Health. 2016 Jul 14. pii: jech-2016-207656. doi: 10.1136/jech-2016-207656. [Epub ahead of print]

PMID:
27417429
2.

Exceptional courses of disease related to the use of complementary and alternative medicine?

Norheim AJ, Fønnebø V, Salamonsen A.

Tidsskr Nor Laegeforen. 2016 Apr 5;136(6):525-6. doi: 10.4045/tidsskr.15.1351. English, Norwegian. No abstract available.

3.

Where Is the Unbiased Information?

Fønnebø VM.

Forsch Komplementmed. 2015;22(6):356-7. doi: 10.1159/000442458. No abstract available.

4.

How do we deal with multiple goals for care within an individual patient trajectory? A document content analysis of health service research papers on goals for care.

Berntsen GK, Gammon D, Steinsbekk A, Salamonsen A, Foss N, Ruland C, Fønnebø V.

BMJ Open. 2015 Dec 10;5(12):e009403. doi: 10.1136/bmjopen-2015-009403.

5.

Use of complementary and alternative medicine within Norwegian hospitals.

Jacobsen R, Fønnebø VM, Foss N, Kristoffersen AE.

BMC Complement Altern Med. 2015 Aug 13;15:275. doi: 10.1186/s12906-015-0782-5.

6.

[Re: A woman in her forties with cancer, syncope and spasms].

Fønnebø V.

Tidsskr Nor Laegeforen. 2015 Jan 27;135(2):104. doi: 10.4045/tidsskr.14.1600. Norwegian. No abstract available.

7.

[V. Fønnebø replies].

Fønnebø V.

Tidsskr Nor Laegeforen. 2014 Sep 2;134(16):1546. doi: 10.4045/tidsskr.14.0923. Norwegian. No abstract available.

8.

Mammography screening should be discontinued.

Fønnebø V.

Tidsskr Nor Laegeforen. 2014 Jun 17;134(11):1127. doi: 10.4045/tidsskr.14.0554. English, Norwegian. No abstract available.

9.

[A research roadmap for complementary and alternative medicine - what we need to know by 2020].

Fischer F, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B.

Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744.

10.

High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research.

Fischer FH, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B.

BMC Complement Altern Med. 2014 Feb 6;14:46. doi: 10.1186/1472-6882-14-46.

11.

Failure to account for selection-bias.

Kalager M, Løberg M, Fønnebø VM, Bretthauer M.

Int J Cancer. 2013 Dec 1;133(11):2751-3. doi: 10.1002/ijc.28244. No abstract available.

12.

Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Kristoffersen AE, Norheim AJ, Fønnebø VM.

Evid Based Complement Alternat Med. 2013;2013:318781. doi: 10.1155/2013/318781.

13.

A pilot feasibility study of a questionnaire to determine European Union-wide CAM use.

Eardley S, Bishop FL, Cardini F, Santos-Rey K, Jong MC, Ursoniu S, Dragan S, Hegyi G, Uehleke B, Vas J, Jupaneant O, Citro MC, Fønnebø V, Quandt SA, Lewith G.

Forsch Komplementmed. 2012;19(6):302-10. doi: 10.1159/000345839.

PMID:
23343585
14.

Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality.

Jørgensen KJ, Kalager M, Zahl PH, Fønnebø VM.

Breast Cancer Res Treat. 2012 Nov;136(2):617-8, author reply 619-20. doi: 10.1007/s10549-012-2250-y. No abstract available.

PMID:
23011508
15.

The NAFKAM International Registry of Exceptional Courses of Disease Related to the Use of Complementary and Alternative Medicine.

Fønnebø V, Drageset BJ, Salamonsen A.

Glob Adv Health Med. 2012 Mar;1(1):60-2. doi: 10.7453/gahmj.2012.1.1.012. Review.

16.

A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.

Salamonsen A, Drageset BJ, Fønnebø V.

Glob Adv Health Med. 2012 Mar;1(1):32-4. doi: 10.7453/gahmj.2012.1.1.009.

17.

Worst Cases Reported to the NAFKAM International Registry of Exceptional Courses of Disease.

Fønnebø V, Drageset BJ, Salamonsen A.

Glob Adv Health Med. 2012 Mar;1(1):30. doi: 10.7453/gahmj.2012.1.1.008. No abstract available.

18.

Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Kristoffersen AE, Norheim AJ, Fønnebø VM.

BMC Complement Altern Med. 2012 Jan 12;12:1. doi: 10.1186/1472-6882-12-1.

19.

Key issues in clinical and epidemiological research in complementary and alternative medicine--a systematic literature review.

Fischer HF, Junne F, Witt C, von Ammon K, Cardini F, Fønnebø V, Johannessen H, Lewith G, Uehleke B, Weidenhammer W, Brinkhaus B.

Forsch Komplementmed. 2012;19 Suppl 2:51-60. doi: 10.1159/000343126. Review.

PMID:
23883945
20.

International development of traditional medicine / complementary and alternative medicine research--what can Europe learn?

Hök J, Lewith G, Weidenhammer W, Santos-Rey K, Fønnebø V, Wiesener S, Falkenberg T.

Forsch Komplementmed. 2012;19 Suppl 2:44-50. doi: 10.1159/000342724.

PMID:
23883944
Items per page

Supplemental Content

Loading ...
Support Center